arrow
S

Sung Hoon Sim

Center for Breast Cancer
H指数:23
被引数:1,503

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)

MIRINAE试验(一项比较辅助阿替利珠单抗联合卡培他滨与单用卡培他滨的随机II期试验;KCSG-BR18-21)中,新辅助化疗后残留浸润性三阴性乳腺癌的基因组学和转录组学分析

2025-09-240
PREAI
Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers
2024-09-270
OAAI
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
2024-08-220
OA
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15)
2024-01-280
OAAI
Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study

使用不同类型癌症患者放化疗期间不良事件通用术语标准的患者报告结果版本监测症状负荷: 真实世界研究

2023-03-089
OAAI